Scenario presets
Operational Cash Flow & Capital Inputs
Economic Return & Valuation Metrics
Calculating CROCI...
- CROCI Return on Capital
- -
- Economic Cash Flow
- -
- Economic Capital Invested
- -
- CROCI vs. WACC Spread
- -
- Economic P/E Multiple
- -
- Maintenance Depreciation
- -
- Capitalized R&D Asset Pool
- -
- Economic Value Creation
- -
Economic Capital & Cash Flow Reconciliation Schedule
Comprehensive reconciliation bridging reported accounting metrics to inflation-adjusted economic capital and true economic cash flow.
| Metric / Valuation Component | Reported Balance ($M) | Economic Adjustment | Economic Value ($M) | Share of Capital (%) |
|---|
Sensitivity Analysis 1: EBITDA vs. Gross Tangible Assets on CROCI (%)
Sensitivity of cash return on capital invested across operating earnings power and physical asset replacement cost.
| EBITDA \ Gross Assets | -40% | -20% | Base ($600M) | +20% | +40% |
|---|
Sensitivity Analysis 2: Economic Cash Flow vs. Enterprise Value on Economic P/E (x)
Institutional equity valuation multiple matrix evaluating market price relative to cash generation.
| Economic CF \ EV | -40% | -20% | Base ($1,500M) | +20% | +40% |
|---|
Formulas and worked example
- Maintenance Depreciation = $\text{Gross Tangible Assets (Replacement)} / \text{Tangible Asset Useful Life}$
- Economic Cash Flow = $\text{EBITDA} - \text{Maintenance Depreciation} - \text{Cash Taxes Paid}$
- Capitalized R&D Asset = $\text{Annual R&D Spend} \times [(\text{R&D Useful Life} + 1) / 2]$
- Economic Capital Invested = $\text{Gross Tangible Assets} + \text{Net Working Capital} + \text{Capitalized R&D Asset}$
- Cash Return on Capital Invested (CROCI) = $(\text{Economic Cash Flow} / \text{Economic Capital Invested}) \times 100\%$
- CROCI Spread = $\text{CROCI} - \text{WACC}$
- Economic P/E Multiple = $\text{Enterprise Value} / \text{Economic Cash Flow}$
- Economic Value Added ($M) = \text{Economic Capital Invested} \times [(\text{CROCI} - \text{WACC}) / 100]$
An enterprise generates $180.0 million in annual EBITDA and trades at a $1,500.0 million Enterprise Value with a 9.0% WACC. It operates $600.0 million in gross tangible assets (12-year average life, yielding $50.0M/yr in economic maintenance depreciation), $80.0 million in net working capital, $25.0 million in cash taxes, and invests $40.0 million annually in R&D with a 5-year amortization horizon. Capitalizing R&D produces a $120.0 million economic asset ($40\text{M} \times 3.0$). Total Economic Capital Invested is $800.0 million ($600\text{M} + 80\text{M} + 120\text{M}$). Economic Cash Flow is $105.0 million ($180\text{M} - 50\text{M} - 25\text{M}$). The resulting CROCI is 13.13% ($105.0\text{M} / 800.0\text{M}$), creating a +4.13 percentage point economic spread above its 9.0% cost of capital ($33.0M annual economic profit), trading at an Economic P/E multiple of 14.29x ($1,500\text{M} / 105\text{M}$).
Self-check quiz
1. Why does CROCI use gross replacement tangible assets rather than net book value of PP&E?
2. How does CROCI treat Research & Development (R&D) expenditures?
3. If a company generates $100M in Economic Cash Flow on $800M of Economic Capital Invested, what is its CROCI?
4. When a company's CROCI is 18.0% and its WACC is 8.0%, what does the +10.0 pp spread indicate to equity analysts?
Frequently asked questions
What is CROCI (Cash Return on Capital Invested) and how is it calculated?
CROCI (Cash Return on Capital Invested) is an institutional valuation metric developed by Deutsche Bank. It measures the cash generated by a business relative to the actual economic replacement cost of its invested capital: CROCI = (Economic Cash Flow / Economic Capital Invested) * 100%. Economic Cash Flow equals EBITDA minus maintenance depreciation and cash taxes, while Economic Capital equals gross tangible replacement assets plus net working capital and capitalized R&D.
How does CROCI correct the accounting flaws of standard ROE and ROIC?
Standard ROE and ROIC rely on historical book value, which makes companies with aging, depreciated machinery look artificially profitable. Furthermore, GAAP and IFRS expense R&D immediately, distorting tech and pharma balance sheets. CROCI levels the playing field by revaluing physical assets at replacement cost and capitalizing R&D investments over their economic life.
What is the CROCI Economic P/E multiple?
The Economic P/E multiple compares a firm's Enterprise Value to its Economic Cash Flow: Economic P/E = Enterprise Value / Economic Cash Flow. By stripping out accounting depreciation discretion and financial leverage distortions, it provides a clean cash-on-cash valuation multiple for cross-border stock comparison.
What constitutes a healthy CROCI-to-WACC economic spread?
A positive spread (CROCI > WACC) demonstrates genuine economic value creation. Institutional investors consider a CROCI spread above +5.0 percentage points as indicative of strong economic moats, pricing power, and durable competitive advantage.